Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Jul;43(7):e38.
doi: 10.1136/jmg.2005.037507.

The 13042G --> A/ND5 mutation in mtDNA is pathogenic and can be associated also with a prevalent ocular phenotype

Affiliations

The 13042G --> A/ND5 mutation in mtDNA is pathogenic and can be associated also with a prevalent ocular phenotype

M L Valentino et al. J Med Genet. 2006 Jul.

Abstract

Background: Overlapping phenotypes including LHON, MELAS, and Leigh syndrome have recently been associated with numerous mtDNA point mutations in the ND5 gene of complex I, now considered a mutational hot spot.

Objective: To identify the mtDNA defect in a family with a prevalent ocular phenotype, including LHON-like optic neuropathy, retinopathy, and cataract, but characterised also by strokes, early deaths, and miscarriages on the maternal line.

Results: Sequencing of the entire mitochondrial genome from the proband's muscle DNA identified the heteroplasmic 13042G-->A transition, which was previously described only once in a patient with a different mitochondrial disease. This mutation fulfils the major pathogenic criteria, inducing an amino acid change (A236T) at an invariant position in a highly conserved domain of the ND5 gene. Phosphorus magnetic resonance spectroscopy in the proband disclosed an in vivo brain and skeletal muscle energy metabolism deficit.

Conclusions: These findings conclusively establish the pathogenic role of the 13042G-->A mutation and underscore its variable clinical expression.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: none declared

Similar articles

Cited by

References

    1. Santorelli F M, Tanji K, Kulikova R, Shanske S, Vilarinho L, Hays A P, DiMauro S. Identification of a novel mutation in the mtDNA ND5 gene associated with MELAS. Biochem Biophys Res Commun 1997238326–328. - PubMed
    1. Pulkes T, Eunson L, Patterson V, Siddiqui A, Wood N W, Nelson I P, Morgan‐Hughes J A, Hanna M G. The mitochondrial DNA G13513A transition in ND5 is associated with a LHON/MELAS overlap syndrome and may be a frequent cause of MELAS. Ann Neurol 199946916–919. - PubMed
    1. Penisson‐Besnier I, Reynier P, Asfar P, Douay O, Sortais A, Dubas F, Emile J, Malthiery Y. Recurrent brain hematomas in MELAS associated with an ND5 gene mitochondrial mutation. Neurology 200055317–318. - PubMed
    1. Corona P, Antozzi C, Carrara F, D'Incerti L, Lamantea E, Tiranti V, Zeviani M. A novel mtDNA mutation in the ND5 subunit of complex I in two MELAS patients. Ann Neurol 200149106–110. - PubMed
    1. Liolitsa D, Rahman S, Benton S, Carr L J, Hanna M G. Is the mitochondrial complex I ND5 gene a hot‐spot for MELAS causing mutations? Ann Neurol 200353128–132. - PubMed

Publication types

Substances